4519.T

Chugai Pharmaceutical Co., Ltd. [4519.T] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

4519.T Stock Summary

Top 10 Correlated ETFs

4519.T

Top 10 Correlated Stocks

4519.T

In the News

4519.T Financial details

Company Rating
-
Market Cap
8616.52B
Income
325.47B
Revenue
1111.37B
Book val./share
-
Cash/share
-
Dividend
80
Dividend %
1.41%
Employees
7.6K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
27.69
Forward P/E
-
PEG
-21.15
P/S
7.09
P/B
6.08
P/C
-
P/FCF
47.44
Quick Ratio
3.54
Current Ratio
4.76
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
197.83
EPS next Y
-
EPS next Q
-
EPS this Y
-13.1%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
15.57%
Revenue last 5Y
10.12%
Revenue Q/Q
6.17%
EPS Q/Q
17.56%
-
-
-
-
SMA20
-8.85%
SMA50
-13.15%
SMA100
-21.21%
Inst Own
-
Inst Trans
-
ROA
19%
ROE
23%
ROC
0.3%
Gross Margin
58%
Oper. Margin
37%
Profit Margin
26%
Payout
39%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3241.0-6697.0
52W High
-9.08%
52W Low
+87.87%
RSI
33
Rel Volume
1.66
Avg Volume
2.34M
Volume
3.88M
Perf Week
-8.44%
Perf Month
-11.56%
Perf Quarter
-30.32%
Perf Half Y
-26.34%
-
-
-
-
Beta
0.469
-
-
Volatility
187.65%, 313.98%
Prev Close
0.94%
Price
6089
Change
1.03%

4519.T Financial Performance

4519.T Dividend History

4519.T Frequently Asked Questions

What is Chugai Pharmaceutical Co., Ltd. stock symbol ?

Chugai Pharmaceutical Co., Ltd. is a JP stock and trading under the symbol 4519.T

What is Chugai Pharmaceutical Co., Ltd. stock quote today ?

Chugai Pharmaceutical Co., Ltd. stock price is $6089 today.

Is Chugai Pharmaceutical Co., Ltd. stock public?

Yes, Chugai Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
CMC.DE
AAPL
VTI
LLY.SW
ABEC.DE
Top Correlated ETFs
ZQB.TO
JRBE.L
FVUG.L
GENY.L
QEBH.TO
Top Correlated Stocks
3834.T
4922.T
7595.T
8214.T
8871.T
Similar Market Cap
022100.KQ
GIAA.JK
051900.KS
259960.KS
012450.KS

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 2.34M
  • Market Capitalization 8616.52B
  • Employee 7.6K
  • CEO Dr. Osamu Okuda
  • Headquarters Tokyo,JP
  • IPO Date 2000-01-04
  • Website https://www.chugai-pharm.co.jp

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.